Hims & Hers Health Inc.

HIMS | NYSE

Price Alert Chart Builder DCF Calculator

$29.35

+$1.36 (+4.86%)

At close: Sep 21, 2026, 4:00 PM ET

$28.83

-$0.52 (-1.77%)

Pre-market: Sep 22, 2026, 4:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $6.24B

Enterprise Value $7.25B

Beta 2.41

Average Volume 17.07M

Shares Outstanding (Diluted) 231.75M

Shares Change YoY -9.75%

Institutional Ownership 65.41%

Exchange NYSE

ISIN US4330001060

Price Performance

Price Change 1M -9.5%

Price Change 3M -10.9%

Price Change 6M 40.8%

Price Change YTD -12.2%

Price Change 1Y -49.1%

Price Change 3Y 388.4%

Price Change 5Y 262.4%

1M CAGR (ann.) -5.6%

1Y CAGR (ann.) -44.4%

5Y CAGR (ann.) 26.3%

All-Time CAGR 16.1%

Valuation

PE Ratio -46.59

Forward PE 82.94

PEG Ratio 1.09

Forward PEG 0.30

PS Ratio 2.54

Forward PS 1.60

PB Ratio 20.20

P/FCF Ratio 72.84

P/Adj. FCF Ratio -102.70

P/OCF Ratio 25.52

EV/Sales 2.81

EV/EBIT -44.33

EV/EBITDA -94.91

EV/FCF 80.69

Earnings Yield -2.1%

FCF Yield 1.4%

Adj. FCF Yield -1.0%

Financial Health

Net Debt $535.8M

Total Debt $1.55B

Cash & Short-Term Investments $841.05M

Total Assets $3.63B

Current Ratio 0.93

Quick Ratio 0.87

Debt / Equity Ratio 4.77

Debt / EBITDA -20.23

Debt / FCF 17.20

OCF / Debt 0.17

Interest Coverage 0.00

Altman Z-Score 1.55

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 64.7%

Operating Profit Margin -3.6%

EBITDA Margin -3.0%

Net Profit Margin -5.5%

FCF Margin 3.5%

Adj. FCF Margin -2.5%

SBC / Revenue 6.0%

SBC Impact (per share) -170.9%

Returns

Return on Assets -3.9%

Return on Equity -30.0%

Return on Invested Capital -3.7%

Return on Capital Employed -4.3%

Return on Tangible Assets -6.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 53.6%

Revenue CAGR 5Y 67.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -429.9%

EPS CAGR 5Y 75.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 97.7%

FCF CAGR 5Y 74.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 20

EPS Growth Next 3Y 76.0%

Revenue Growth Next 3Y 24.5%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $32.17

Price Target Upside 9.6%

Cash Flow

Operating Cash Flow $266.84M

Free Cash Flow $89.89M

Adj. Free Cash Flow $-63.75M

FCF Per Share $0.39

OCF Per Share $1.15

OCF/S Ratio 10.4%

Income Statement

Revenue $2.58B

Gross Profit $1.67B

Operating Income $-92.67M

EBITDA $-76.42M

Net Income $-142.03M

EPS (Diluted) -$0.63

Revenue / Employee $1.06M

Profit / Employee $-58.16K

Employees 2,442